U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07305844) titled 'Open-label, Single-arm Study to Assess the Colonization Kinetics of Clinician- Administered Vaginal Live Biotherapeutic Product Containing Multiple Strains of Lactobacillus Crispatus.' on Dec. 12.
Brief Summary: This is an open-label, single-arm, Phase Ib trial assessing the consistency of response and colonization kinetics of a vaginally inserted live biotherapeutic intervention with optimized adherence.
Study Start Date: Feb. 10, 2026
Study Type: INTERVENTIONAL
Condition:
Bacterial Vaginosis
Intervention:
DRUG: LC106
This is a 6-strain L. crispatus vaginal live biotherapeutic tablet
Recruitment Status: NOT_YET_RECRUITING
...